World Health Organization site
Skip Navigation Links
Advanced Search
List ByExpand List By
Search Tips
ICTRP websiteExpand ICTRP website
Contact us
                   588 records for 496 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02910310
Introduction of UBT for PPH Management in Three Countries
Not recruitingNCT02905890
The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis
Performance evaluation of a point-of-care whole blood viral load test (SAMBA II HIV-1 Semi-Q Whole Blood) to optimise HIV treatment
Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
Innovative Behavioral Economics Incentives Strategies for Health
A randomized controlled evaluation of an intervention package to improve health services for chronic diseases in Uganda and Tanzania
Not RecruitingPACTR201608001738234
Social, Emotional and Economic empowerment thru Knowledge of Group Support Psychotherapy content (SEEK-GSP) Trial
Not recruitingNCT02904928
Incidence and Perioperative Factors Associated With Postoperative Delirium
'HI-4-TU' Study: Health Improvement for Teen Ugandans Study
Not AvailableEUCTR2016-002345-39-Outside-EU/EEA
This study will test an experimental drug named GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) for the possible treatment of human immunodeficiency virus (HIV) infection in children and adolescents. The purpose of this study is to determine the concentration of GS-9883 in your child’s body, and confirm the safety, tolerability and dose of GS-9883/F/TAF in HIV-1 infected, virologically suppressed adolescents (12 to < 18 years of age) and children (6 to < 12 years of age).
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history